As part of its Researching COVID to Enhance Recovery (RECOVER) Initiative, NIH has opened enrollment for clinical trials at sites around the country that will test potential treatments for Long COVID. Treatments include drugs, biologics, medical devices, and other therapies. A protocol that will be launched n the coming months will study treatments related to symptoms of the autonomic nervous system and the first trials will focus on treatments for people who develop postural orthostatic tachycardia syndrome (POTS) following SARS-CoV-2 infection.Read More »
As It Relates To Autoimmune Disease
COVID News & Research Updates
Want to know what's going on in coronavirus news? Check out our ongoing timeline summarizing key COVID-19 scientific developments, especially as they pertain to autoimmune disease.